Filter
News & Insights
- Compliance & Legal, Biotech & Pharma
Partners in progress: How Novo Nordisk transformed compliance into strategy
Read More - Clinical & Medical AffairsClinical Insider
Digital twins could help patients get more from automated insulin delivery, study finds
Read More - Clinical & Medical AffairsClinical Insider
US FDA plans to use AI to accelerate clinical trial reviews
Read More - Clinical & Medical AffairsClinical Insider
ICON launches multi-indication trial design service for obesity drugs
Read More - Compliance & Legal, Biotech & Pharma
Social media and pharma, a necessary presence riddled with risks
Read More - Compliance & Legal, Biotech & Pharma
Bridging business and ethics: A pharmaceutical compliance leader’s perspective
Read More - Wealth & Investment Management
Where to seek opportunities in an era of geopolitical transformation?
Read More - Channel
VMware Battles on Many Fronts – Rivals, Channel and Customers
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Sourcing Biotech Innovation in China: Perspectives from the Frontline, Special Report
Read More - Compliance & Legal, Biotech & Pharma
A fine balance with health systems’ HCP interactions
Read More - Compliance & Legal, Biotech & Pharma
Industry examples offer a blueprint for stronger compliance
Read More - Finance & Accounting, Life Sciences
CFO panel discussion showcases what finance professionals bring to the table
Read More - Private Capital
The numbers behind SuperVenture 2025
Read More - Private Capital
Navigating the energy transition: Blackstone's blueprint for success
Read More - Private Capital
SuperReturn Webinar: How is AI disrupting private capital?
Read More - IGM
CREDIT OPEN: Risk switch back in the on position
Read More - IGM
[MORNING CALL] Seven Days in May
Read More - IGM
North American FX Open - Usd lifted by Fed's wait and see stance
Read More - IGM
Asian FX Close: Soft tone in the dollar in Asian session as markets pare back some of the US-China trade talk optimism
Read More - IGM
CEEMEA OPEN: A measured issuance week so far, but backdrop still supportive
Read More